Atrial fibrillation (AF) is A serious risk element for stroke, and for decades the anticoagulant warfarin was the normal remedy for reducing that hazard. Having said that, various drug and food stuff interactions make warfarin burdensome for people. A new course of drugs—non–vitamin K antagonist oral anticoagulants (NOACs)—have emerged in its